Abstract
The claimant, the United States Anti-Doping Agency (“USADA”), is the independent anti-doping agency for Olympic sports in the United States and is responsible for managing the testing and adjudication process for doping control in that country. The respondent, Tim Montgomery, was an elite and highly successful American track and field athlete. As a sprinter, he had won numerous track and field titles, including World Championship and Olympic gold medals, as well as a world record. In 2004, USADA informed Montgomery that it had received sufficient evidence to indicate that he was a participant in a wide-ranging doping conspiracy implemented by the Californian-based Bay Area Laboratory Cooperative (“BALCO”). USADA sought to ban Montgomery for four years. The legal issue revolved around the fact that USADA had charged Montgomery with the violation of applicable IAAF (athletics’ world governing body) anti-doping rules, notwithstanding that Montgomery had never tested positive in any in-competition or out-of-competition doping test. The matter proceeded directly to a single final hearing before the Court of Arbitration for Sport (“CAS”). A CAS Panel held that doping offences can be proved by a variety of means and thus, for instance, in the absence of any adverse analytical finding, other types of evidence can be substantiated. Among these “alternatives” could be uncontroverted testimony of a wholly credible witness, sufficient to establish that the athlete has admitted to the use of prohibited substances in violation of applicable anti-doping rules. In addition, CAS held that USADA bore the burden of proving, by strong evidence commensurate with the serious claims at issue, that the athlete had committed the doping offences. An important aspect of the CAS award was the discussion on whether a “beyond reasonable doubt” or “comfortable satisfaction” standard of proof should apply in determining doping claims against athletes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
- 2.
Modahl v British Athletic Federation (No 2) [2001] EWCA Civ 1447; [2002] 1 WLR 1192, 1208.
- 3.
See further Ruijsenaars et al. 2007.
- 4.
Case C-519/04 P David Meca-Medina and Igor Majcen v Commission of the European Communities [2006] ECR I-6991.
- 5.
Weatherill 2006, 657.
- 6.
- 7.
CAS 2004/O/645 USADA v Montgomery.
- 8.
In the early part of this century, Californian-based Bay Area Laboratory Cooperative (“BALCO”) was involved in a conspiracy the purpose of which was the distribution and use of sports doping substances and techniques that were either undetectable or difficult to detect in routine drug testing. The affair prompted numerous public and sport-specific investigations, including the stated proceedings. For its origins, see generally Fainaru-Wada and Williams 2006.
- 9.
Under Article 4.3.1 of the 2009 WADA Code, a substance or method shall be considered for inclusion on the Prohibited List if WADA determines that it meets any two of the following three criteria: 4.3.1.1 Medical or other scientific evidence, pharmacological effect or experience that the substance or method, alone or in combination with other substances or methods, has the potential to enhance or enhances sport performance; 4.3.1.2 Medical or other scientific evidence, pharmacological effect or experience that the Use of the substance or method represents an actual or potential health risk to the Athlete; 4.3.1.3 WADA's determination that the Use of the substance or method violates the spirit of sport described in the Introduction to the Code. Under Article 4.3.2 of the 2009 Code, a substance or method shall also be included on the Prohibited List if WADA determines there is medical or other scientific evidence, pharmacological effect or experience that the substance or method has the potential to mask the Use of other Prohibited Substances or Prohibited Methods.
- 10.
Beloff 2000, 40.
- 11.
De Knop 2000, 20.
- 12.
- 13.
See generally Oschutz 2002.
- 14.
Under the 2009 WADA Code, the definition of a doping offence under Article 1 is the violation of an anti-doping rule contained in Article 2. They are: the presence of a prohibited substance or its metabolites in an athlete’s sample (Article 2.1); use or attempted use by an athlete of a prohibited substance or a prohibited method (Article 2.2); refusing or failing without compelling justification to sample collection (Article 2.3); violation of applicable requirements regarding athlete availability for out-of-competition testing (Article 2.4); tampering or attempted tampering with any part of doping control (Article 2.5); possession of prohibited substances or prohibited methods (Article 2.6); trafficking or attempted trafficking in any prohibited substance or prohibited method (Article 2.7) and administration or attempted administration to any athlete of any prohibited method or prohibited substance. (Article 2.8).
- 15.
For an early discussion and recognition of strict liability in doping-related sports disputes see CAS 94/129 USA Shooting & Quigley v UIT and Tarasti 2000.
- 16.
CAS 98/211 B v FINA.
- 17.
CAS OG 96/003-004 Korneev and Ghouliev v IOC.
- 18.
CAS 2004/A/651 French v Australian Sports Commission and Cycling Australia.
- 19.
But see CAS 2004/0/607 B v IWF.
- 20.
Arbitral Award AAA no 30 190 00658 04 USADA v Collins. This award was heard before the American Arbitration Association under the auspices of a North American Court of Arbitration for Sport Panel and is available online at: www.usada.org/files/active/arbitration_rulings/AAA%20CAS%20Decision%20-%20Collins.pdf.
- 21.
CAS 2004/0/649 USADA v Gaines.
- 22.
CAS 2004/O/645 USADA v Montgomery, para 3.
- 23.
CAS 2004/O/645 USADA v Montgomery, para 4.
- 24.
CAS 2004/O/645 USADA v Montgomery, para 8.
- 25.
CAS 2004/O/645 USADA v Montgomery, para 5.
- 26.
For the sake of accuracy it should be noted that the CAS Panel had addressed the question of the standard of proof applicable in the present case at a preliminary hearing on 4 March 2005, referred to in the final award as the “Decision on Evidentiary and Procedural Issues”.
- 27.
CAS 2004/O/645 USADA v Montgomery, paras 10–12. USADA requested a doping ban of four years on the basis that IAAF Rule 60 defined the appropriate sanction as being of a minimum of two years. CAS, adopting the sanctions prescribed in the WADA Code, imposed a sanction of two years.
- 28.
See generally Roberts 2007.
- 29.
Soek 2000, 73.
- 30.
- 31.
If there ever was any!
- 32.
Another American sprinter whose record of five World Champion titles and four Olympic medals eclipses that of Montgomery.
- 33.
Associated Press 2009.
- 34.
BBC Sport Online 2005.
References
Associated Press (2009) Montgomery obsessed with Greene. http://sports.espn.go.com/oly/news/story?id=4693099. Accessed 31 July 2012
Bailey D (2007) Taking the governance of sport out of court. Sports Law Adm Pract (June):5–6
BBC Sport Online (2005) Montgomery hit with two-year ban. http://news.bbc.co.uk/sport1/hi/athletics/4521452.stm. Accessed 31 July 2012
Beloff M (2000) Drugs, laws and versapaks. In: O’Leary J (ed) Drugs and doping in sport. Cavendish, London
Beloff M (2009) Fair play—is there still room for the Corinthian spirit in sport? Int Sports Law Rev 3:34–44
Casini L (2009) Global hybrid public-private bodies: the world anti-doping agency. Int Organ Law Rev 6:421–446
De Knop P (2000) Globalisation, Americanization and localization in sport. Int Sports Law J 2:20–21
Fainaru-Wada M, Williams L (2006) Game of shadows. Gotham, New York
Green S (2004) Cheating. Law Philos 23:135–187
Manville A (2008) European Court vs sports organisations—who will win the antitrust competition? Int Sports Law J 3/4:19–26
Marshall J, Hale A (2008) Will the new WADA code plug all the gaps? Will there be by-catch? Int Sports Law J 1/2:37–42
Oschutz F (2002) Harmonisation of anti doping code through arbitration: the case law of the Court of Arbitration for Sport. Marquette Sports Law Rev 12:675–702
Pijetlovic K (2009) Paragraph 31 of C-519/04 Meca-Medina reversed. Int Sports Law J 1/2:137–138
Roberts H (2007) BALCO and Beyond: The changing landscape in the fight against doping in sport. Sport Law Adm Pract (August):1–7
Ruijsenaars P et al (2007) Manifesto: stop the doping inquisition! Int Sports Law J 3/4:84–85
Soek J (2000) The fundamental rights of athletes in doping trials. In: O’Leary J (ed) Drugs and doping in sport. Cavendish, London
Subiotto R (2010) The adoption and enforcement of anti-doping rules should not be subject to European competition law. Eur Compet Law Rev 31:323–330
Szyszczak E (2007) Competition and sport. Eur Law Rev 32:95–110
Tarasti L (2000) Legal solutions in international doping cases. SEP Editrice, Milan
Tarasti L (2008) Some juridical question marks in the revised world anti-doping code. Int Sports Law J 2/3:17–23
Teitler S and Ram H (2008) Analysing the new world anti-doping code: a different perspective. Int Sports Law J 1/2:42–49
Walker N (2010) Out of place and out of time: law’s fading co-ordinates. Edinb Law Rev 14:13–46
Weatherill S (2006) Anti-doping revisited—the demise of the rule of ‘purely sporting’ interest? Eur Compet Law Rev 27:645–657
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 T.M.C. ASSER PRESS, The Hague, The Netherlands, and the author(s)
About this chapter
Cite this chapter
O’Leary, J. (2013). CAS 2004/O/645 USADA v Montgomery . In: Anderson, J. (eds) Leading Cases in Sports Law. ASSER International Sports Law Series. T.M.C. Asser Press, The Hague, The Netherlands. https://doi.org/10.1007/978-90-6704-909-2_12
Download citation
DOI: https://doi.org/10.1007/978-90-6704-909-2_12
Published:
Publisher Name: T.M.C. Asser Press, The Hague, The Netherlands
Print ISBN: 978-90-6704-908-5
Online ISBN: 978-90-6704-909-2
eBook Packages: Humanities, Social Sciences and LawLaw and Criminology (R0)